临床医学工程2016，Vol.23Issue(4)：483-484,2.DOI:10.3969/j.issn.1674-4659.2016.04.0483
瑞替普酶静脉溶栓与PCI治疗急性心肌梗死的疗效对比
Effect Comparison of Reteplase Intravenous Thrombolysis and Percutaneous Coronary Intervention in Treatment of Acute Myocardial Infarction
黄丹丹 1廖成标 1乐建华 1张惠琪 1蒋爱忠1
作者信息
- 1. 广东省河源市人民医院心内科，广东河源517000
- 折叠
摘要
Abstract
Objective To compare the clinical efficacy of reteplase intravenous thrombolysis and percutaneous coronary intervention (PCI) in treatment of acute myocardial infarction (AMI). Methods The clinical data of 81 AMI patients were retrospectively analyzed. All patients were divided into two groups according to different treatment methods:PCI group (41 cases), reteplase intravenous thrombolysis group (40 cases). The prognosis conditions and adverse cardiovascular events were compared. Results The time of accepting myocardial revascularization in thrombolysis group was timely than that in PCI group (P<0.05), the peak value of CK-MB was higher than that in PCI group, the conditions of hemorrhage and malignant arrhythmia were more serious than that in PCI group , the LVEF value was lower than that in PCI group (P<0.05). Conclusions PCI is superior to reteplase intravenous thrombolysis in treatment of acute myocardial infarction.关键词
急性心肌梗死/急诊PCI/瑞替普酶Key words
Acute myocardial infarction/Emergency PCI/Reteplase分类
医药卫生引用本文复制引用
黄丹丹,廖成标,乐建华,张惠琪,蒋爱忠..瑞替普酶静脉溶栓与PCI治疗急性心肌梗死的疗效对比[J].临床医学工程,2016,23(4):483-484,2.
